A pharmacodynamic comparison of human urinary follicle-stimulating hormone and human menopausal gonadotropin in normal women and polycystic ovary syndrome**Supported in part by grant MO1-RR-43 from the General Clinical Research Centers Program of the Division of Research Resources, National Institutes of Health, Bethesda, Maryland, and by a grant from Serono Laboratories, Inc., Norwell, Massachusetts.
1989 ◽
Vol 52
(2)
◽
pp. 216-220
◽
1990 ◽
Vol 31
(3)
◽
pp. 304-304
1995 ◽
Vol 10
(5)
◽
pp. 1054-1059
◽
1984 ◽
Vol 41
(5)
◽
pp. 719-725
◽
2007 ◽
Vol 92
(5)
◽
pp. 1871-1874
◽
1985 ◽
Vol 43
(4)
◽
pp. 549-553
◽
2015 ◽
Vol 81
(2)
◽
pp. 118-123
◽
1985 ◽
Vol 43
(5)
◽
pp. 703-708
◽